Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alkermes plc stock logo
ALKS
Alkermes
$28.81
-0.1%
$29.98
$22.90
$36.45
$4.75B0.471.73 million shs2.94 million shs
Envista Holdings Corporation stock logo
NVST
Envista
$19.69
+0.2%
$17.80
$14.22
$23.00
$3.33B0.992.50 million shs2.56 million shs
Organon & Co. stock logo
OGN
Organon & Co.
$9.87
-1.1%
$9.77
$8.01
$23.10
$2.56B0.583.50 million shs4.46 million shs
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$15.93
-0.4%
$15.39
$12.16
$27.95
$3.17B0.952.94 million shs3.05 million shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alkermes plc stock logo
ALKS
Alkermes
0.00%-0.96%-4.76%-13.25%+17.26%
Envista Holdings Corporation stock logo
NVST
Envista
0.00%+4.29%+6.39%+16.04%+19.23%
Organon & Co. stock logo
OGN
Organon & Co.
0.00%+1.07%+3.50%-32.01%-52.14%
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
0.00%+3.71%-2.45%+6.70%-36.69%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alkermes plc stock logo
ALKS
Alkermes
4.9048 of 5 stars
4.43.00.04.22.92.51.9
Envista Holdings Corporation stock logo
NVST
Envista
3.4331 of 5 stars
2.23.00.03.81.50.01.9
Organon & Co. stock logo
OGN
Organon & Co.
4.8834 of 5 stars
3.34.01.73.71.73.32.5
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
4.8135 of 5 stars
3.15.04.23.83.01.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alkermes plc stock logo
ALKS
Alkermes
2.83
Moderate Buy$40.0038.84% Upside
Envista Holdings Corporation stock logo
NVST
Envista
2.33
Hold$20.232.77% Upside
Organon & Co. stock logo
OGN
Organon & Co.
2.50
Moderate Buy$18.0082.39% Upside
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
2.15
Hold$20.3627.83% Upside

Current Analyst Ratings Breakdown

Latest NVST, XRAY, OGN, and ALKS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/17/2025
Alkermes plc stock logo
ALKS
Alkermes
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$33.00 ➝ $42.00
5/28/2025
Alkermes plc stock logo
ALKS
Alkermes
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral ➝ Buy$45.00
5/27/2025
Envista Holdings Corporation stock logo
NVST
Envista
Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
5/27/2025
Envista Holdings Corporation stock logo
NVST
Envista
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Outperform$21.00 ➝ $23.00
5/22/2025
Organon & Co. stock logo
OGN
Organon & Co.
BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/15/2025
Organon & Co. stock logo
OGN
Organon & Co.
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$24.00 ➝ $18.00
5/13/2025
Alkermes plc stock logo
ALKS
Alkermes
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/12/2025
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$20.00 ➝ $21.00
5/9/2025
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$27.00 ➝ $25.00
5/5/2025
Envista Holdings Corporation stock logo
NVST
Envista
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$21.00 ➝ $18.00
5/5/2025
Organon & Co. stock logo
OGN
Organon & Co.
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$15.00 ➝ $10.00
(Data available from 6/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alkermes plc stock logo
ALKS
Alkermes
$1.56B3.05$2.65 per share10.87$9.05 per share3.18
Envista Holdings Corporation stock logo
NVST
Envista
$2.51B1.33$1.66 per share11.84$17.05 per share1.15
Organon & Co. stock logo
OGN
Organon & Co.
$6.40B0.40$4.93 per share2.00$1.83 per share5.39
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$3.79B0.84$7.38 per share2.16$9.77 per share1.63
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alkermes plc stock logo
ALKS
Alkermes
$367.07M$2.0913.7821.031.7923.30%27.52%17.98%7/23/2025 (Estimated)
Envista Holdings Corporation stock logo
NVST
Envista
-$1.12B-$6.53N/A16.271.25-44.90%4.07%2.25%8/6/2025 (Estimated)
Organon & Co. stock logo
OGN
Organon & Co.
$864M$2.883.432.641.0311.92%227.43%7.34%8/5/2025 (Estimated)
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
-$910M-$4.54N/A8.381.14-24.42%14.31%5.37%7/30/2025 (Estimated)

Latest NVST, XRAY, OGN, and ALKS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/23/2025Q2 2025
Alkermes plc stock logo
ALKS
Alkermes
$0.42N/AN/AN/A$343.20 millionN/A
5/8/2025Q1 2025
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$0.29$0.43+$0.14$0.10$854.75 million$879.00 million
5/1/2025Q1 2025
Alkermes plc stock logo
ALKS
Alkermes
$0.32$0.13-$0.19$0.13$307.53 million$306.51 million
5/1/2025Q1 2025
Envista Holdings Corporation stock logo
NVST
Envista
$0.20$0.24+$0.04$0.10$608.17 million$616.90 million
5/1/2025Q1 2025
Organon & Co. stock logo
OGN
Organon & Co.
$0.89$1.02+$0.13$0.33$1.53 billion$1.51 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alkermes plc stock logo
ALKS
Alkermes
N/AN/AN/AN/AN/A
Envista Holdings Corporation stock logo
NVST
Envista
N/AN/AN/AN/AN/A
Organon & Co. stock logo
OGN
Organon & Co.
$0.080.81%N/A2.78%N/A
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$0.644.02%N/AN/A 13 Years

Latest NVST, XRAY, OGN, and ALKS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/21/2025
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
quarterly$0.163.92%6/27/20256/27/20257/11/2025
5/2/2025
Organon & Co. stock logo
OGN
Organon & Co.
quarterly$0.020.8%5/12/20255/12/20256/12/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alkermes plc stock logo
ALKS
Alkermes
N/A
3.33
2.92
Envista Holdings Corporation stock logo
NVST
Envista
0.43
2.12
1.82
Organon & Co. stock logo
OGN
Organon & Co.
16.49
1.67
1.15
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
0.79
1.10
0.76

Institutional Ownership

CompanyInstitutional Ownership
Alkermes plc stock logo
ALKS
Alkermes
95.21%
Envista Holdings Corporation stock logo
NVST
Envista
N/A
Organon & Co. stock logo
OGN
Organon & Co.
77.43%
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
95.70%

Insider Ownership

CompanyInsider Ownership
Alkermes plc stock logo
ALKS
Alkermes
4.40%
Envista Holdings Corporation stock logo
NVST
Envista
1.30%
Organon & Co. stock logo
OGN
Organon & Co.
1.96%
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
0.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alkermes plc stock logo
ALKS
Alkermes
1,800164.90 million157.65 millionOptionable
Envista Holdings Corporation stock logo
NVST
Envista
12,300169.49 million167.28 millionOptionable
Organon & Co. stock logo
OGN
Organon & Co.
4,000259.96 million254.86 millionNot Optionable
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
14,000199.29 million198.30 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Alkermes stock logo

Alkermes NASDAQ:ALKS

$28.81 -0.02 (-0.07%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$29.10 +0.29 (+1.02%)
As of 06/27/2025 07:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. It has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; and LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

Envista stock logo

Envista NYSE:NVST

$19.68 +0.04 (+0.18%)
Closing price 06/27/2025 03:59 PM Eastern
Extended Trading
$19.60 -0.09 (-0.46%)
As of 06/27/2025 05:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Organon & Co. stock logo

Organon & Co. NYSE:OGN

$9.87 -0.11 (-1.11%)
Closing price 06/27/2025 03:59 PM Eastern
Extended Trading
$9.86 0.00 (-0.04%)
As of 06/27/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

DENTSPLY SIRONA stock logo

DENTSPLY SIRONA NASDAQ:XRAY

$15.93 -0.07 (-0.44%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$15.83 -0.10 (-0.63%)
As of 06/27/2025 06:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform. It also provides endodontic products consisting of motorized endodontic handpieces, files, sealers, irrigation needles, and other tools that support root canal procedures; restorative products, including dental ceramics, crowns, and veneers; and preventative products, such as curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, and impression materials. In addition, the company offers SureSmile and Byte aligner solutions; VPro/HyperByte, a high-frequency vibration technology device; SureSmile Simulator, which creates a 3D visualization of a patient's outcome; and Byte Plus for treatment planning. Further, it provides dental implants, digital dentures, crown and bridge porcelain products, bone regenerative and restorative solutions, treatment planning software, and educational programs; dental prosthetics; urology catheters; and other health-related consumables. The company serves professional dental and consumable medical device markets through third-party distributors. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina